GCG and myeloid sarcoma: Some studies have shown the effects of MS on intestinal physiology, neural signaling, intestinal incretin secretion, BA metabolism, and microbiota changes, which may be closely related to the improvement in glucose metabolism after MS (Breen et al., 2012; Affinati et al., 2019).